• 8-26-2021

Case Study: Eligibility Data (Increased HCP Exposure)

A pharmaceutical company looking to raise awareness for an injectable drug therapy that treats acute attacks of Hereditary Angioedema (HAE) used DeepIntent’s Eligibility Data to reach HCPs and drive new patient starts at 2.5 times their return on investment.

Download Now

More Insights

Case Studies
Revolutionizing Healthcare Advertising: How DeepIntent Outcomes™ Delivers Exceptional Performance for Leading Pharma Brands
5-25-2023
Proven to drive audience quality (AQ) and script lift, DeepIntent Outcomes™ is the industry's fastest cross-platform measurement solution based on clinical data. Download our eBooklet...
Read More
DTC Outcomes Migraine
Case Studies
Case Study: Migraine Brand Accelerates Reach to Precise Patient Population While Reducing Cost-Per-Verified-Patient by 50%
10-25-2022
Using a combination of Patient Modeled Audiences and DeepIntent Outcomes™, learn how one pharma brand exceeded their Patient Reach Guarantee by 10% and lowered their...
Read More
Prescriptions Over Impressions
Case Studies
Case Study: Prescriptions Over Impressions​: Matterkind and DeepIntent Prove Addressable Media Drives Script Performance and New Patient Starts​
6-15-2022
How does addressable media impact script performance? DeepIntent helped one top pharmaceutical company and its agency of record, Matterkind, answer that question with an integrated,...
Read More
Back to Top